Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rieckmann

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2011
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) studyS Cook, P Vermersch, G Comi, et al.
Neurology|September 30, 2009
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trialW King Engel, F Fazekas, F D Lublin, et al.
Acta Neurologica Scandinavica|September 21, 2010
More CLEC16A gene variants associated with multiple sclerosisS Nischwitz, S Cepok, A Kroner, et al.
Der Nervenarzt|April 5, 2005
[MS registry in Germany--design and first results of the pilot phase]P Flachenecker, U K Zettl, U Götze, et al.
Genes and Immunity|August 21, 2009
The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravisW-Y Chuang, P Ströbel, D Belharazem, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
Patient-reported quality of life in multiple sclerosis differs between cultures and countries: a cross-sectional Austrian-German-Polish studyA Pluta-Fuerst, K Petrovic, T Berger, et al.
The Journal of Pathology|March 6, 2007
Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1)P Ströbel, A Murumägi, R Klein, et al.
Lancet (London, England)|October 10, 2009
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trialG Comi, V Martinelli, M Rodegher, et al.
Neurobiology of Aging|August 21, 2003
Combination of serum markers related to several mechanisms in Alzheimer's diseaseC E Teunissen, D Lütjohann, K von Bergmann, et al.
Journal of Neuroinflammation|December 17, 2015
Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MSL Schrewe, C M Lill, T Liu, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2011
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) studyS Cook, P Vermersch, G Comi, et al.
Neurology|September 30, 2009
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trialW King Engel, F Fazekas, F D Lublin, et al.
Acta Neurologica Scandinavica|September 21, 2010
More CLEC16A gene variants associated with multiple sclerosisS Nischwitz, S Cepok, A Kroner, et al.
Der Nervenarzt|April 5, 2005
[MS registry in Germany--design and first results of the pilot phase]P Flachenecker, U K Zettl, U Götze, et al.
Genes and Immunity|August 21, 2009
The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravisW-Y Chuang, P Ströbel, D Belharazem, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
Patient-reported quality of life in multiple sclerosis differs between cultures and countries: a cross-sectional Austrian-German-Polish studyA Pluta-Fuerst, K Petrovic, T Berger, et al.
The Journal of Pathology|March 6, 2007
Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1)P Ströbel, A Murumägi, R Klein, et al.
Lancet (London, England)|October 10, 2009
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trialG Comi, V Martinelli, M Rodegher, et al.
Neurobiology of Aging|August 21, 2003
Combination of serum markers related to several mechanisms in Alzheimer's diseaseC E Teunissen, D Lütjohann, K von Bergmann, et al.
Journal of Neuroinflammation|December 17, 2015
Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MSL Schrewe, C M Lill, T Liu, et al.
Pageof 15